Dr Mark Farrow

University position

Programme Manager

Departments

Department of Engineering

Research Theme

Cellular and Molecular Neuroscience

Interests

Targeted delivery of therapeutics for hard-to-treat cancers

Research Focus

Keywords

None specified

Clinical conditions

Cancers

Equipment

No equipment indicated

Collaborators

No collaborators listed

Associated News Items


    Publications

    2018

    Purro SA, Farrow MA, Linehan J, Nazari T, Thomas DX, Chen Z, Mengel D, Saito T, Saido T, Rudge P, Brandner S, Walsh DM, Collinge J. (2018), “Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.” Nature 564(7736): 415-419

    2017

    Sarell CJ, Quarterman E, Yip DC, Terry C, Nicoll AJ, Wadsworth JDF, Farrow MA, Walsh DM, Collinge J (2017), “Soluble Aβ aggregates can inhibit prion propagation.” Open Biol 2017 7(11)

    2015

    Risse E, Nicoll AJ, Taylor WA, Wright D, Badoni M, Yang X, Farrow MA, Collinge J (2015), “Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.” J Biol Chem 290(27):17020-8

    2013

    Nicoll AJ, Panico S, Freir DB, Wright D, Terry C, Risse E, Herron CE, O'Malley T, Wadsworth JD, Farrow MA, Walsh DM, Saibil HR, Collinge J (2013), “Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity.” Nat Commun. 4:2416

    2012

    Klöhn PC, Farmer M, Linehan JM, O'Malley C, Fernandez de Marco M, Taylor W, Farrow M, Khalili-Shirazi A, Brandner S, Collinge J (2012), “PrP antibodies do not trigger mouse hippocampal neuron apoptosis.” Science 335(6064):52